Latest news
FDA Grants Fast Track Designation to BioInvent's BI-1808 for Ovarian Cancer - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 18:25:09 GMTBioInvent wins FDA Fast Track for BI-1808 after encouraging ovarian cancer data - AllSciAllSci · Fri, 07 Aug 2026 16:28:01 GMTBioInvent says FDA grants Fast Track designation for BI-1808 plus Keytruda in ovarian cancer - BitgetBitget · Fri, 07 Aug 2026 09:21:36 GMTBioInvent Receives FDA Fast Track Designation for BI-1808 for the Treatment of Ovarian Cancer - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 09:20:00 GMTBioInvent says FDA grants Fast Track designation for BI-1808 in ovarian cancer - BitgetBitget · Fri, 07 Aug 2026 09:19:03 GMTBitcoin Whales Continue Accumulating BTC, They’ve Purchased $1.2 Billion Worth of BTC! Here Are the Details - BitgetBitget · Fri, 07 Aug 2026 09:04:26 GMTBioInvent International AB Revenue Breakdown – OMXSTO:BINV - TradingViewTradingView · Sat, 01 Aug 2026 04:51:40 GMTBioInvent strengthens the mechanistic basis for BI-1206 in new JECCR publication - BiostockBiostock · Tue, 28 Jul 2026 19:15:58 GMT